Article Versions Notes

Gilio L, Buttari F, Pavone L, Iezzi E, Galifi G, Dolcetti E, Azzolini F, Bruno A, Borrelli A, Storto M, et al. Fatigue in Multiple Sclerosis Is Associated with Reduced Expression of Interleukin-10 and Worse Prospective Disease Activity. Biomedicines. 2022; 10(9):2058. https://doi.org/10.3390/biomedicines10092058

Gilio, Luana, Fabio Buttari, Luigi Pavone, Ennio Iezzi, Giovanni Galifi, Ettore Dolcetti, Federica Azzolini, Antonio Bruno, Angela Borrelli, Marianna Storto, and et al. 2022. "Fatigue in Multiple Sclerosis Is Associated with Reduced Expression of Interleukin-10 and Worse Prospective Disease Activity" Biomedicines 10, no. 9: 2058. https://doi.org/10.3390/biomedicines10092058

Gilio, L., Buttari, F., Pavone, L., Iezzi, E., Galifi, G., Dolcetti, E., Azzolini, F., Bruno, A., Borrelli, A., Storto, M., Furlan, R., Finardi, A., Pekmezovic, T., Drulovic, J., Mandolesi, G., Fresegna, D., Vanni, V., Centonze, D., & Stampanoni Bassi, M. (2022). Fatigue in Multiple Sclerosis Is Associated with Reduced Expression of Interleukin-10 and Worse Prospective Disease Activity. Biomedicines, 10(9), 2058. https://doi.org/10.3390/biomedicines10092058